Prascend tablets are a veterinary medication specifically designed to treat horses suffering from Pituitary Pars Intermedia Dysfunction (PPID), commonly known as Equine Cushing's Disease. Each tablet contains 1 mg of pergolide mesylate, a powerful ingredient that helps control the clinical signs of this condition. Administered orally once daily, Prascend tablets are essential for managing the symptoms and improving the quality of life for horses with Equine Cushing's Disease.
Key Features:
Active Ingredient: Contains 1 mg of pergolide mesylate per tablet
Indication: Treats Pituitary Pars Intermedia Dysfunction (Equine Cushing's Disease)
Dosage: Oral administration, once daily as prescribed
Dosage Range: 0.5 to 4 tablets per day, as prescribed, based on horse's weight
Dosing Regimen:
300 to 749 lbs.: 0.5 to 1 tablet daily
750 to 1,249 lbs.: 1 to 2 tablets daily
1,250 to 1,749 lbs.: 1.5 to 3 tablets daily
1,750 to 2,249 lbs.: 2 to 4 tablets daily
Benefits of Prascend Tablets for Horses:
Effective Symptom Control: Manages clinical signs of Equine Cushing's Disease
Improved Quality of Life: Enhances overall well-being of affected horses
Precise Dosage: Dosing tailored to the horse's weight for optimal results
Veterinarian Recommended: Trusted by equine health professionals
Why Choose Prascend Tablets?
Targeted Treatment: Specifically designed for PPID in horses
Easy Administration: Convenient oral tablets for daily use
Reliable Performance: Proven effectiveness in managing Equine Cushing's Disease symptoms
Comprehensive Care: Supports long-term health and quality of life for horses
For effective management of Equine Cushing's Disease, trust Prascend tablets. Follow the prescribed dosage regimen to ensure your horse receives the best possible care, leading to improved health and comfort
Shipping Restrictions: The following may not be shippable to the specified states: GU, VI
